23andMe co-founder Anne Wojcicki discusses how doctors are handling patients who bring the genetic code to the office, and how more patients will pick and choose treatments based on their genetic makeup.Wojcicki was part of a panel discussion at the Cleveland Clinic Medical Innovation Summit on Tuesday discussing the market for consumer genotyping and its application in characterizing genes associated with cancer.
Link to this comment:
All Comments (0)